SI

Sam Isaly

North America, New York, United States, New York

Description

Samuel D. Isaly is Managing Partner and Founder of Exome Asset Management. Sam Isaly is an experienced healthcare fund manager and has been ...

Investor Profile

Sam Isaly has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series D (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sam Isaly frequently co-invest with?

Yuexiu Group
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 1
CCBT Private Equity
Asia, Beijing, China, Beijing
Co-Investments: 1
B
Asia, Beijing, China, Beijing
Co-Investments: 1
CE
Asia, Fujian, China, Xiamen
Co-Investments: 1
Dingxin Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
CS
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Exome Asset Management
North America, New York, United States, New York
Co-Investments: 1
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 1

What are some of recent deals done by Sam Isaly?

IMPACT Therapeutics

Nanjing, Jiangsu, China

IMPACT Therapeutics is a therapeutics company dedicated to the development of similar drugs to treat cancer.

BiotechnologyPharmaceuticalTherapeutics
Series DMar 14, 2022